The validation of the Helicobacter pylori CagA typing by immunohistochemistry: nationwide application in Indonesia
The validation of the Helicobacter pylori CagA typing by immunohistochemistry: nationwide application in Indonesia
复制标题
DOI:
10.1016/j.acthis.2020.151594
复制
发表时间:
2020-09-01
影响因子:
2.5
通讯作者:
Yamaoka, Yoshio
中科院分区:
文献类型:
--
作者:
Miftahussurur, Muhammad;Dalla Doohan;Yamaoka, Yoshio
We aimed to validate 2 types of antibodies, anti-CagA antibody and anti-East Asian CagA specific antibody (alpha-EAS antibody) for the determination of CagA status in Indonesia. We also confirmed the performance of alpha-EAS antibody for the detection of East Asian-type CagA H. pylori. Immunohistochemistry was performed using anti-CagA antibody and alpha-EAS antibody on gastric biopsy specimens from a total of 967 Indonesian patients. Diagnostic values of immunohistochemistry were evaluated with PCR-based sequencing as gold standard. Anti-CagA antibody had high sensitivity, specificity, and accuracy (87.0 %, 100 %, and 98.8 %, respectively) for determining CagA status. The alpha-EAS antibody was not suitable for the purpose of CagA status determination, as it had a low sensitivity (23.9 %). High specificity (97.6 %) but low sensitivity (41.2 %) and accuracy (66.3 %) was observed in alpha-EAS antibody to detect East Asian-type CagA. Patients with positive result of immunohistochemistry using anti-CagA antibody had significantly higher monocyte infiltration score in antrum (P < 0.001) and corpus (P = 0.009). In conclusion, the anti-CagA antibody is still suitable to be used in Indonesia for determining the CagA status, whilst the alpha-EAS antibody was not appropriate to discriminate between East Asian-type and non-East Asian-type CagA in Indonesia.